Ginkgo Bioworks Holdings (DNA) Operating Margin (2020 - 2026)

Ginkgo Bioworks Holdings has reported Operating Margin for 7 years, with the latest figure at 366.51% in Q1 2026.

• For the quarter ending Q1 2026, Operating Margin fell 15471.0% year-over-year to 366.51%; the trailing twelve-month figure through Mar 2026 stood at 210.66% (down 711.0% YoY), and the FY2025 full-year result was 185.29%, up 6125.0% from the prior year.
• Operating Margin for Q1 2026 stood at 366.51%, down from 211.86% in the prior quarter.
• The five-year high for Operating Margin was 61.99% in Q3 2024, with the low at 986.38% in Q3 2022.
• Historically, Operating Margin has averaged 347.85% across 5 years, with a median of 267.34% in 2023.
• The largest YoY upside for Operating Margin was 89966 bps in 2022 against a maximum downside of 95202 bps in 2022.
• Ginkgo Bioworks Holdings' Operating Margin stood at 234.89% in 2022, then slumped by 118 bps to 512.49% in 2023, then soared by 54 bps to 236.29% in 2024, then advanced by 10 bps to 211.86% in 2025, then plunged by 73 bps to 366.51% in 2026.
• The last three Operating Margin figures came in at 366.51% (Q1 2026), 211.86% (Q4 2025), and 231.78% (Q3 2025), per Business Quant data.